Cytochrome P450 1A1
Details
- Name
- Cytochrome P450 1A1
- Synonyms
- 1.14.14.1
- CYPIA1
- Cytochrome P450 form 6
- Cytochrome P450-C
- Cytochrome P450-P1
- Gene Name
- CYP1A1
- Organism
- Humans
- Amino acid sequence
>lcl|BSEQ0006827|Cytochrome P450 1A1 MLFPISMSATEFLLASVIFCLVFWVIRASRPQVPKGLKNPPGPWGWPLIGHMLTLGKNPH LALSRMSQQYGDVLQIRIGSTPVVVLSGLDTIRQALVRQGDDFKGRPDLYTFTLISNGQS MSFSPDSGPVWAARRRLAQNGLKSFSIASDPASSTSCYLEEHVSKEAEVLISTLQELMAG PGHFNPYRYVVVSVTNVICAICFGRRYDHNHQELLSLVNLNNNFGEVVGSGNPADFIPIL RYLPNPSLNAFKDLNEKFYSFMQKMVKEHYKTFEKGHIRDITDSLIEHCQEKQLDENANV QLSDEKIINIVLDLFGAGFDTVTTAISWSLMYLVMNPRVQRKIQEELDTVIGRSRRPRLS DRSHLPYMEAFILETFRHSSFVPFTIPHSTTRDTSLKGFYIPKGRCVFVNQWQINHDQKL WVNPSEFLPERFLTPDGAIDKVLSEKVIIFGMGKRKCIGETIARWEVFLFLAILLQRVEF SVPLGVKVDMTPIYGLTMKHACCEHFQMQLRS
- Number of residues
- 512
- Molecular Weight
- 58164.815
- Theoretical pI
- 8.47
- GO Classification
- Functionsaromatase activity / demethylase activity / flavonoid 3'-monooxygenase activity / heme binding / iron ion binding / monooxygenase activity / oxidoreductase activity / oxidoreductase activity, acting on diphenols and related substances as donors / oxygen binding / steroid hydroxylase activity / vitamin D 24-hydroxylase activityProcesses9-cis-retinoic acid biosynthetic process / aging / amine metabolic process / arachidonic acid metabolic process / camera-type eye development / cell proliferation / cellular lipid metabolic process / cellular response to organic cyclic compound / coumarin metabolic process / dibenzo-p-dioxin catabolic process / digestive tract development / drug metabolic process / embryo development ending in birth or egg hatching / epoxygenase P450 pathway / flavonoid metabolic process / hepatocyte differentiation / hydrogen peroxide biosynthetic process / insecticide metabolic process / maternal process involved in parturition / omega-hydroxylase P450 pathway / oxidation-reduction process / porphyrin-containing compound metabolic process / positive regulation of G1/S transition of mitotic cell cycle / response to antibiotic / response to arsenic-containing substance / response to drug / response to food / response to herbicide / response to hyperoxia / response to hypoxia / response to immobilization stress / response to iron(III) ion / response to lipopolysaccharide / response to nematode / response to virus / response to vitamin A / response to wounding / small molecule metabolic process / vitamin D metabolic process / xenobiotic metabolic processComponentsendoplasmic reticulum membrane / mitochondrion
- General Function
- Vitamin d 24-hydroxylase activity
- Specific Function
- Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics.
- Pfam Domain Function
- p450 (PF00067)
- Transmembrane Regions
- Not Available
- Cellular Location
- Endoplasmic reticulum membrane
- Gene sequence
>lcl|BSEQ0012466|Cytochrome P450 1A1 (CYP1A1) ATGCTTTTCCCAATCTCCATGTCGGCCACGGAGTTTCTTCTGGCCTCTGTCATCTTCTGT CTGGTATTCTGGGTAATCAGGGCCTCAAGACCTCAGGTCCCCAAAGGCCTGAAGAATCCA CCAGGGCCATGGGGCTGGCCTCTGATTGGGCACATGCTGACCCTGGGAAAGAACCCGCAC CTGGCACTGTCAAGGATGAGCCAGCAGTATGGGGACGTGCTGCAGATCCGAATTGGCTCC ACACCCGTGGTGGTGCTGAGCGGCCTGGACACCATCCGGCAGGCCCTGGTGCGGCAGGGC GATGATTTCAAGGGCCGGCCCGACCTCTACACCTTCACCCTCATCAGTAATGGTCAGAGC ATGTCCTTCAGCCCAGACTCTGGACCAGTGTGGGCTGCCCGCCGGCGCCTGGCCCAGAAT GGCCTGAAAAGTTTCTCCATTGCCTCTGACCCAGCCTCCTCAACCTCCTGCTACCTGGAA GAGCATGTGAGCAAGGAGGCTGAGGTCCTGATAAGCACGTTGCAGGAGCTGATGGCAGGG CCTGGGCACTTTAACCCCTACAGGTATGTGGTGGTATCAGTGACCAATGTCATCTGTGCC ATTTGCTTTGGCCGGCGCTATGACCACAACCACCAAGAACTGCTTAGCCTAGTCAACCTG AATAATAATTTCGGGGAGGTGGTTGGCTCTGGAAACCCAGCTGACTTCATCCCTATTCTT CGCTACCTACCCAACCCTTCCCTGAATGCCTTCAAGGACCTGAATGAGAAGTTCTACAGC TTCATGCAGAAGATGGTCAAGGAGCACTACAAAACCTTTGAGAAGGGCCACATCCGGGAC ATCACAGACAGCCTGATTGAGCACTGTCAGGAGAAGCAGCTGGATGAGAACGCCAATGTC CAGCTGTCAGATGAGAAGATCATTAACATCGTCTTGGACCTCTTTGGAGCTGGGTTTGAC ACAGTCACAACTGCTATCTCCTGGAGCCTCATGTATTTGGTGATGAACCCCAGGGTACAG AGAAAGATCCAAGAGGAGCTAGACACAGTGATTGGCAGGTCACGGCGGCCCCGGCTCTCT GACAGATCCCATCTGCCCTATATGGAGGCCTTCATCCTGGAGACCTTCCGACACTCTTCC TTCGTCCCCTTCACCATCCCCCACAGCACAACAAGAGACACAAGTTTGAAAGGCTTTTAC ATCCCCAAGGGGCGTTGTGTCTTTGTAAACCAGTGGCAGATCAACCATGACCAGAAGCTA TGGGTCAACCCATCTGAGTTCCTACCTGAACGGTTTCTCACCCCTGATGGTGCTATCGAC AAGGTGTTAAGTGAGAAGGTGATTATCTTTGGCATGGGCAAGCGGAAGTGTATCGGTGAG ACCATTGCCCGCTGGGAGGTCTTTCTCTTCCTGGCTATCCTGCTGCAACGGGTGGAATTC AGCGTGCCACTGGGCGTGAAGGTGGACATGACCCCCATCTATGGGCTAACCATGAAGCAT GCCTGCTGTGAGCACTTCCAAATGCAGCTGCGCTCTTAG
- Chromosome Location
- 15
- Locus
- 15q24.1
- External Identifiers
Resource Link UniProtKB ID P04798 UniProtKB Entry Name CP1A1_HUMAN GenBank Protein ID 181276 GenBank Gene ID K03191 HGNC ID HGNC:2595 - General References
- Jaiswal AK, Gonzalez FJ, Nebert DW: Human P1-450 gene sequence and correlation of mRNA with genetic differences in benzo[a]pyrene metabolism. Nucleic Acids Res. 1985 Jun 25;13(12):4503-20. [Article]
- Jaiswal AK, Gonzalez FJ, Nebert DW: Human dioxin-inducible cytochrome P1-450: complementary DNA and amino acid sequence. Science. 1985 Apr 5;228(4695):80-3. [Article]
- Kawajiri K, Watanabe J, Gotoh O, Tagashira Y, Sogawa K, Fujii-Kuriyama Y: Structure and drug inducibility of the human cytochrome P-450c gene. Eur J Biochem. 1986 Sep 1;159(2):219-25. [Article]
- Corchero J, Pimprale S, Kimura S, Gonzalez FJ: Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation. Pharmacogenetics. 2001 Feb;11(1):1-6. [Article]
- Zody MC, Garber M, Sharpe T, Young SK, Rowen L, O'Neill K, Whittaker CA, Kamal M, Chang JL, Cuomo CA, Dewar K, FitzGerald MG, Kodira CD, Madan A, Qin S, Yang X, Abbasi N, Abouelleil A, Arachchi HM, Baradarani L, Birditt B, Bloom S, Bloom T, Borowsky ML, Burke J, Butler J, Cook A, DeArellano K, DeCaprio D, Dorris L 3rd, Dors M, Eichler EE, Engels R, Fahey J, Fleetwood P, Friedman C, Gearin G, Hall JL, Hensley G, Johnson E, Jones C, Kamat A, Kaur A, Locke DP, Madan A, Munson G, Jaffe DB, Lui A, Macdonald P, Mauceli E, Naylor JW, Nesbitt R, Nicol R, O'Leary SB, Ratcliffe A, Rounsley S, She X, Sneddon KM, Stewart S, Sougnez C, Stone SM, Topham K, Vincent D, Wang S, Zimmer AR, Birren BW, Hood L, Lander ES, Nusbaum C: Analysis of the DNA sequence and duplication history of human chromosome 15. Nature. 2006 Mar 30;440(7084):671-5. [Article]
- Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article]
- Yun CH, Park HJ, Kim SJ, Kim HK: Identification of cytochrome P450 1A1 in human brain. Biochem Biophys Res Commun. 1998 Feb 24;243(3):808-10. [Article]
- Quattrochi LC, Okino ST, Pendurthi UR, Tukey RH: Cloning and isolation of human cytochrome P-450 cDNAs homologous to dioxin-inducible rabbit mRNAs encoding P-450 4 and P-450 6. DNA. 1985 Oct;4(5):395-400. [Article]
- Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article]
- Walsh AA, Szklarz GD, Scott EE: Human cytochrome P450 1A1 structure and utility in understanding drug and xenobiotic metabolism. J Biol Chem. 2013 May 3;288(18):12932-43. doi: 10.1074/jbc.M113.452953. Epub 2013 Mar 18. [Article]
- Hayashi S, Watanabe J, Nakachi K, Kawajiri K: Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J Biochem. 1991 Sep;110(3):407-11. [Article]
- Cascorbi I, Brockmoller J, Roots I: A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res. 1996 Nov 1;56(21):4965-9. [Article]
- Smart J, Daly AK: Variation in induced CYP1A1 levels: relationship to CYP1A1, Ah receptor and GSTM1 polymorphisms. Pharmacogenetics. 2000 Feb;10(1):11-24. [Article]
- Chevalier D, Allorge D, Lo-Guidice JM, Cauffiez C, Lhermitte M, Lafitte JJ, Broly F: Detection of known and two novel (M331I and R464S) missense mutations in the human CYP1A1 gene in a French Caucasian population. Hum Mutat. 2001 Apr;17(4):355. [Article]
- Saito T, Egashira M, Kiyotani K, Fujieda M, Yamazaki H, Kiyohara C, Kunitoh H, Kamataki T: Novel nonsynonymous polymorphisms of the CYP1A1 gene in Japanese. Drug Metab Pharmacokinet. 2003;18(3):218-21. [Article]
- Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, Ihrie P, Mehall JM, Edwards TL, Dawson EP: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics. 2004 Oct;5(7):895-931. [Article]
- Jiang Z, Dalton TP, Jin L, Wang B, Tsuneoka Y, Shertzer HG, Deka R, Nebert DW: Toward the evaluation of function in genetic variability: characterizing human SNP frequencies and establishing BAC-transgenic mice carrying the human CYP1A1_CYP1A2 locus. Hum Mutat. 2005 Feb;25(2):196-206. [Article]
- Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE: The consensus coding sequences of human breast and colorectal cancers. Science. 2006 Oct 13;314(5797):268-74. Epub 2006 Sep 7. [Article]
Drug Relations
- Drug Relations
DrugBank ID Name Drug group Pharmacological action? Actions Details DB00851 Dacarbazine approved, investigational unknown substrate Details DB00170 Menadione approved, nutraceutical unknown inhibitorinducer Details DB00176 Fluvoxamine approved, investigational unknown inhibitor Details DB00356 Chlorzoxazone approved unknown substrate Details DB00468 Quinine approved unknown inhibitorinducer Details DB00655 Estrone approved unknown substrate Details DB00730 Thiabendazole approved, vet_approved unknown inducer Details DB00889 Granisetron approved, investigational unknown substrate Details DB00908 Quinidine approved, investigational unknown inhibitor Details DB01026 Ketoconazole approved, investigational unknown inhibitorinducer Details DB01087 Primaquine approved unknown inducer Details DB04905 Tesmilifene investigational unknown substrate Details DB02709 Resveratrol investigational no substrateinhibitor Details DB04957 Azimilide investigational unknown substrate Details DB01065 Melatonin approved, nutraceutical, vet_approved unknown substrateinhibitor Details DB00381 Amlodipine approved unknown inhibitor Details DB00675 Tamoxifen approved unknown substrate Details DB00972 Azelastine approved unknown substrateinhibitor Details DB00568 Cinnarizine approved, investigational unknown substrate Details DB04841 Flunarizine approved unknown substrate Details DB01118 Amiodarone approved, investigational unknown substrate Details DB01136 Carvedilol approved, investigational unknown substrate Details DB01095 Fluvastatin approved unknown substrateinducer Details DB00818 Propofol approved, investigational, vet_approved unknown inhibitor Details DB00518 Albendazole approved, vet_approved unknown inducer Details DB00613 Amodiaquine approved, investigational unknown substrate Details DB01393 Bezafibrate approved, investigational unknown inducer Details DB00201 Caffeine approved unknown inhibitor Details DB00608 Chloroquine approved, investigational, vet_approved unknown substrate Details DB01407 Clenbuterol approved, investigational, vet_approved unknown substrate Details DB00636 Clofibrate approved, investigational unknown inducer Details DB00363 Clozapine approved no inducer Details DB00169 Cholecalciferol approved, nutraceutical unknown inhibitor Details DB04840 Debrisoquine approved, investigational unknown substrate Details DB01234 Dexamethasone approved, investigational, vet_approved unknown inhibitorinducer Details DB00783 Estradiol approved, investigational, vet_approved unknown substrate Details DB00898 Ethanol approved unknown inhibitor Details DB00499 Flutamide approved, investigational unknown substrate Details DB01064 Isoprenaline approved, investigational unknown inhibitorinducer Details DB01167 Itraconazole approved, investigational no inducer Details DB00448 Lansoprazole approved, investigational unknown inducer Details DB00643 Mebendazole approved, vet_approved unknown inducer Details DB00553 Methoxsalen approved unknown inhibitor Details DB00184 Nicotine approved unknown substrateinducer Details DB01115 Nifedipine approved unknown inhibitor Details DB00325 Nitroprusside approved, investigational unknown inhibitor Details DB01059 Norfloxacin approved unknown inhibitor Details DB00338 Omeprazole approved, investigational, vet_approved unknown substrateinducer Details DB03783 Phenacetin withdrawn unknown substrate Details DB00396 Progesterone approved, vet_approved unknown substrate Details DB00571 Propranolol approved, investigational unknown inhibitor Details DB01129 Rabeprazole approved, investigational unknown inducer Details DB00740 Riluzole approved, investigational unknown substrate Details DB00605 Sulindac approved, investigational unknown inhibitor Details DB00624 Testosterone approved, investigational unknown substrate Details DB00277 Theophylline approved unknown substrateinhibitor Details DB00539 Toremifene approved, investigational unknown substrate Details DB00197 Troglitazone approved, investigational, withdrawn unknown inducer Details DB00530 Erlotinib approved, investigational unknown substrate Details DB00738 Pentamidine approved, investigational unknown substrate Details DB00755 Tretinoin approved, investigational, nutraceutical unknown substrate Details DB01254 Dasatinib approved, investigational unknown substrate Details DB00575 Clonidine approved unknown substrate Details DB02342 2-Methoxyestradiol investigational unknown Details DB04975 Banoxantrone investigational unknown substrate Details DB06770 Benzyl alcohol approved unknown inhibitor Details DB00633 Dexmedetomidine approved, vet_approved unknown inhibitor Details DB00466 Picrotoxin experimental unknown inducer Details DB00428 Streptozocin approved, investigational unknown inducer Details DB00165 Pyridoxine approved, investigational, nutraceutical, vet_approved no inhibitor Details DB01174 Phenobarbital approved, investigational unknown inducer Details DB04871 Lorcaserin approved, withdrawn no substrate Details DB08846 Ellagic acid investigational unknown inhibitorinducer Details DB00317 Gefitinib approved, investigational unknown substrateinhibitor Details DB06292 Dapagliflozin approved no substrate Details DB06176 Romidepsin approved, investigational unknown substrate Details DB08931 Riociguat approved no substrate Details DB01685 Topiroxostat experimental unknown inhibitor Details DB08922 Perospirone experimental unknown substrate Details DB12379 Indirubin investigational unknown substrate Details DB09238 Manidipine approved, investigational unknown inhibitor Details DB09061 Cannabidiol approved, investigational unknown inhibitor Details DB13943 Testosterone cypionate approved unknown substrate Details DB13944 Testosterone enanthate approved unknown substrate Details DB13946 Testosterone undecanoate approved, investigational unknown substrate Details DB13952 Estradiol acetate approved, investigational, vet_approved unknown substrate Details DB13953 Estradiol benzoate approved, investigational, vet_approved unknown substrate Details DB13954 Estradiol cypionate approved, investigational, vet_approved unknown substrate Details DB13955 Estradiol dienanthate approved, investigational, vet_approved unknown substrate Details DB13956 Estradiol valerate approved, investigational, vet_approved unknown substrate Details DB14009 Medical Cannabis experimental, investigational unknown inhibitorinducer Details DB11155 Triclocarban approved unknown inducer Details DB06654 Safinamide approved, investigational unknown inhibitor Details DB05928 Dovitinib investigational unknown inducer Details DB08496 (R)-warfarin experimental unknown substrate Details DB00550 Propylthiouracil approved, investigational no inducer Details DB12245 Triclabendazole approved, investigational unknown substrate Details DB00455 Loratadine approved, investigational no substrate Details DB01591 Solifenacin approved unknown substrate Details DB00502 Haloperidol approved unknown substrate Details DB11757 Istradefylline approved, investigational unknown substrate Details DB11511 Difloxacin vet_approved unknown substrate Details DB14011 Nabiximols investigational unknown inhibitor Details DB01132 Pioglitazone approved, investigational unknown substrate Details DB14649 Dexamethasone acetate approved, investigational, vet_approved unknown inhibitorinducer Details DB15305 Risdiplam approved, investigational unknown substrate Details DB12483 Copanlisib approved, investigational unknown substrate Details DB01381 Ginkgo biloba approved, investigational, nutraceutical no inhibitor Details DB08995 Diosmin approved, investigational unknown inducer Details DB16165 Finerenone approved, investigational unknown substrate Details DB00470 Dronabinol approved, illicit no inhibitorinducer Details DB14737 Cannabinol experimental, investigational unknown inhibitor Details DB01041 Thalidomide approved, investigational, withdrawn no substrate Details DB16217 Leniolisib approved, investigational no substrate Details